Skip Page Header

Home > Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association.

American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health, Council on Quality of Care and Outcomes Research. Medical marijuana, recreational cannabis, and cardiovascular health. Paige II, Robert L and Allen, Larry A and Kloner, Robert A and Carriker, Colin R and Martel, Catherine and Morris, Alanna A and Piano, Mariann R and Rana, Jamal S and Saucedo, Jorge F (2020) Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association. Circulation , 142 . doi: 10.1161/CIR.0000000000000883.

URL: https://www.ahajournals.org/doi/10.1161/CIR.000000...

Cannabis, or marijuana, has potential therapeutic and medicinal properties related to multiple compounds, particularly Δ-9-tetrahydrocannabinol and cannabidiol. Over the past 25 years, attitudes toward cannabis have evolved rapidly, with expanding legalization of medical and recreational use at the state level in the United States and recreational use nationally in Canada and Uruguay. As a result, the consumption of cannabis products is increasing considerably, particularly among youth. Our understanding of the safety and efficacy of cannabis has been limited by decades of worldwide illegality and continues to be limited in the United States by the ongoing classification of cannabis as a Schedule 1 controlled substance. These shifts in cannabis use require clinicians to understand conflicting laws, health implications, and therapeutic possibilities. Cannabis may have therapeutic benefits, but few are cardiovascular in nature. Conversely, many of the concerning health implications of cannabis include cardiovascular diseases, although they may be mediated by mechanisms of delivery. This statement critically reviews the use of medicinal and recreational cannabis from a clinical but also a policy and public health perspective by evaluating its safety and efficacy profile, particularly in relationship to cardiovascular health.


Item Type
Article
Publication Type
International, Open Access, Review
Drug Type
Cannabis
Intervention Type
Drug therapy, Treatment method, Harm reduction
Date
August 2020
Identification #
doi: 10.1161/CIR.0000000000000883
Publisher
American Heart Association
Corporate Creators
American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health, Council on Quality of Care and Outcomes Research. Medical marijuana, recreational cannabis, and cardiovascular health
Volume
142
EndNote
Related URLs

Repository Staff Only: item control page